Investor Trieu Vuong
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Trieu Vuong . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2019-05-03 13D 691828404 / Mateon Therapeutics, Inc. 113,867,439 113,867,439
2019-05-02 13D 691828404 / Mateon Therapeutics, Inc. 113,867,439
2018-04-27 13D/A 56804Q201 / Marina Biotech, Inc. 39,473,553 11,219,002
2016-11-23 13D ATRX / Adhera Therapeutics, Inc. 39,473,553